CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Que Dallara

Chief Executive Officer, Minimed

Search every verified Que Dallara interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Que Dallara, chief executive officer of MiniMed, has described the company's goal as becoming the "self-driving car of diabetes care," with automated insulin delivery systems intended to reduce the burden of daily diabetes management. In a May 2026 interview following MiniMed's initial public offering, Dallara said the company serves patients who need insulin and builds technology that automates dosing, noting that adoption of such automation remains in the low double digits globally. Dallara also stated that GLP-1 therapies do not remove the need for insulin and that the company focuses on insulin delivery for type 1 and type 2 diabetes. Dallara has discussed MiniMed's history and strategy in several appearances. In late 2025, Dallara spoke about the company's transition from Medtronic Diabetes, its new MiniMed name, and the development of the 780G system, which she described as a second-generation algorithm with auto-corrections every five minutes. She also acknowledged past challenges, including a warning letter that delayed the 780G's market entry, and referenced the "innovator's dilemma" as a common cycle for companies. In 2024, Dallara discussed a partnership with Abbott to develop a continuous glucose monitor for the Medtronic ecosystem, emphasizing a turnkey approach where patients deal with a single company for support. During Medtronic's fiscal 2025 earnings call, she expressed excitement about leading the independent diabetes business, which she said has over 8,000 employees and two global manufacturing facilities.

Recent appearances

  • MiniMed Aims to Be 'Self-Driving Car' of Diabetes Care

    May 15, 2026 · 📺 Bloomberg Tech

    Diabetes equipment provider MiniMed is aiming to be the “self-driving car” of insulin pumps, says its CEO, Que Dallara. Hot off the heels of the company’s IPO, Dallara speaks with Caroline Hyde on the sidelines of the Consello Spark Summit. -------- Like this video? Subscribe to Bloomberg Technology on YouTube:    / @bloombergtech     Watch the latest full episodes of "Bloomberg Technology" with Caroline Hyde and Ed Ludlow here:    • 'Bloomberg Tech' With Ed Ludlow Full Episodes     Get the latest in tech from Silicon Valley and around the world here: https://www.bloomberg.com/technol…

    Watch on YouTube ↗

  • #1697 Que Dallara, EVP & President at Medtronic Diabetes

    December 01, 2025 · 📺 Juicebox Podcast

    Scott talks with MiniMed leader Que Dallara about her refugee-to-CEO story, Medtronic’s spin-off, new MiniMed name, 780G automation, upcoming sensors and pumps, and the dream of hands-free diabetes tech. Medtronic Diabetes Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Tandem Mobi ** twiist AID System Drink AG1.com/Juicebox Use code JUICEBOX to save 40% at Cozy Earth CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US ME…

    Watch on YouTube ↗

  • Medtronic (MDT) Q4 FY 2025 Earnings – Full Coverage

    May 24, 2025 · 📺 Fyfull

    *Medtronic (MDT) Q4 FY 2025 Earnings – Full Coverage* *Key Highlights:* *Financials* – Q4 FY 2025 revenue $8,900M (+5.4% organic), adj. EPS $1.62 (+11%); FY revenue +5%, EPS +6%; dividend up for 48th year; tariff impact $200-350M in FY26; diabetes separation announced (IPO/split-off, 18 months). *Operations* – Cardiovascular +8% (CAS +30%), neuromodulation +10%, diabetes +12%, cranial/spinal +7% US; Afera PFA, Evolut TAVR, Inceptiv SCS, MiniMed 780G drive growth; Hugo robot and Simplera CGM advance. *Strategy* – CEO Jeff Martha emphasized durable growth drivers (PFA, RDN, Able ecosystem…

    Watch on YouTube ↗

  • Medtronic & Abbott Partnership Details- Interview with Que Dallara from Medtronic

    September 21, 2024 · 📺 Nerdabetic

    At the EASD conference, I had the privilege of sitting down with Que Dallara, President of the Diabetes Operating Unit at Medtronic. We explored the launch of Simplera Sync and then dove into the unexpected news of Medtronic's recent partnership with Abbott to develop an exclusive CGM for the Medtronic ecosystem. I hope you find the interview insightful! 0:00 Simplera Sync Rollout Update 2:02 Abbott & Medtronic Partnership- Why 6:13 Details about the agreement 8:35 Medtronic Commitment ******************************************* My email address: [email protected] My Instagram:   / nerd…

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →